← All trials
NCT00281294
Phase 2Interventional
Includes controlled clinical studies conducted to evaluate the effectiveness of the drug for a particular indication or indications in participants with the disease or condition under study and to determine the common short-term side effects and risks.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 1, 2005
- Primary completion
- —
- Completion date
- Dec 1, 2006
- First posted
- —
- Last posted
- —
- Enrollment
- 40
- Arms / groups
- — / —
- Source
- AACT · pre-existing
Sponsors
- PDL BioPharmaLead sponsor
- Michigan State UniversityOverall official - principal investigator
- Denver Arthritis ClinicOverall official - principal investigator
- Altoona Center for Clinical ResearchOverall official - principal investigator
- Coeur d Alene Arthritis ClinicOverall official - principal investigator
- Wallace Rheumatic Study CenterOverall official - principal investigator
- Stanford UniversityOverall official - principal investigator
- Virginia Mason Medical CenterOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.